RESULTS. : Biopsy-proven glomerular disease recurrence was similar in patients induced with alemtuzumab or IL-2 receptor antagonists.
结果：在用阿仑单抗治疗或白细胞介素-2受体拮抗剂治疗患者中的活组织检查出肾小球疾病复发率相似。
Starting about a week before the transplant, the patients also received a drug called alemtuzumab which destroyed circulating native white blood cells so they couldn't attack the transplanted cells.
移植前一周，患者授受一种称为阿仑单抗的药。该药破坏循环中的自然白细胞，使之丧失攻击移植细胞能力。
Starting about a week before the transplant, the patients also received a drug called alemtuzumab which destroyed circulating native white blood cells so they couldn't attack the transplanted cells.
移植前一周，患者授受一种称为阿仑单抗的药。该药破坏循环中的自然白细胞，使之丧失攻击移植细胞能力。
应用推荐